Metlife (MET) Notes Payables (2009 - 2026)

Metlife has reported Notes Payables for 18 years, with the latest figure at $460.0 million in Q2 2026.

• On a quarterly basis, Notes Payables rose 21.37% year-over-year to $460.0 million in Q2 2026; TTM through Jun 2026 was $460.0 million, a 21.37% increase from a year earlier, with the FY2025 full-year figure at $355.0 million, down 23.66% from the prior year.
• Notes Payables was $460.0 million for Q2 2026 at Metlife, up from $404.0 million in the prior quarter.
• The five-year high for Notes Payables was $465.0 million in Q4 2024, with the low at $119.0 million in Q4 2023.
• Average Notes Payables over 5 years is $292.7 million, with a median of $339.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Notes Payables sank 50.13% in 2022, then jumped 290.76% in 2024.
• Over 5 years, Notes Payables stood at $175.0 million in 2022, then slumped by 32.0% to $119.0 million in 2023, then surged by 290.76% to $465.0 million in 2024, then slipped by 23.66% to $355.0 million in 2025, then climbed by 29.58% to $460.0 million in 2026.
• The last three Notes Payables figures came in at $460.0 million (Q2 2026), $404.0 million (Q1 2026), and $355.0 million (Q4 2025), per Business Quant data.